title: Rapamycin reduces rejection in heart transplant recipients.
authors.affiliation: Texas Heart Institute, Houston, Texas 77030, USA
authors.forename: B
authors.initials: B
authors.lastname: Radovancevic
authors.forename: R
authors.initials: R
authors.lastname: El-Sabrout
authors.forename: C
authors.initials: C
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Radovancevic
authors.forename: O H
authors.initials: OH
authors.lastname: Frazier
authors.forename: C
authors.initials: C
authors.lastname: Van Buren
mesh_terms: D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005006:Ethnicity; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000627:therapeutic use*; D013781:Texas
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus